FDA.reportPublic FDA data

Application 201677

Type
ANDA
Sponsor
LUPIN LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001VALSARTANVALSARTANTABLET;ORAL40MGNoNo
002VALSARTANVALSARTANTABLET;ORAL80MGNoNo
003VALSARTANVALSARTANTABLET;ORAL160MGNoNo
004VALSARTANVALSARTANTABLET;ORAL320MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
68180-276ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-276ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-276ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-276ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-277ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-277ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-277ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-277ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-278ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-278ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-278ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-278ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-279ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-279ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-279ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent
68180-279ValsartanValsartanLupin Pharmaceuticals, Inc.ANDACurrent